share_log

HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $8 Price Target

Benzinga ·  Aug 1 06:22

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Processa Pharma (NASDAQ:PCSA) with a Buy and maintains $8 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment